JP2011522553A5 - - Google Patents

Download PDF

Info

Publication number
JP2011522553A5
JP2011522553A5 JP2011512983A JP2011512983A JP2011522553A5 JP 2011522553 A5 JP2011522553 A5 JP 2011522553A5 JP 2011512983 A JP2011512983 A JP 2011512983A JP 2011512983 A JP2011512983 A JP 2011512983A JP 2011522553 A5 JP2011522553 A5 JP 2011522553A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
growth factor
interleukin
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011512983A
Other languages
English (en)
Japanese (ja)
Other versions
JP5632833B2 (ja
JP2011522553A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/057232 external-priority patent/WO2009150199A1/en
Publication of JP2011522553A publication Critical patent/JP2011522553A/ja
Publication of JP2011522553A5 publication Critical patent/JP2011522553A5/ja
Application granted granted Critical
Publication of JP5632833B2 publication Critical patent/JP5632833B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011512983A 2008-06-11 2009-06-11 肝臓前駆細胞の馴化培地 Active JP5632833B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08010651 2008-06-11
EP08010651.1 2008-06-11
PCT/EP2009/057232 WO2009150199A1 (en) 2008-06-11 2009-06-11 Conditioned medium of liver progenitor cells

Publications (3)

Publication Number Publication Date
JP2011522553A JP2011522553A (ja) 2011-08-04
JP2011522553A5 true JP2011522553A5 (https=) 2012-07-12
JP5632833B2 JP5632833B2 (ja) 2014-11-26

Family

ID=40905279

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011512983A Active JP5632833B2 (ja) 2008-06-11 2009-06-11 肝臓前駆細胞の馴化培地

Country Status (12)

Country Link
US (2) US10456425B2 (https=)
EP (1) EP2296672B1 (https=)
JP (1) JP5632833B2 (https=)
CN (2) CN102119031B (https=)
BR (1) BRPI0909866B1 (https=)
CA (1) CA2727392C (https=)
DK (1) DK2296672T3 (https=)
ES (1) ES2556630T3 (https=)
HU (1) HUE028676T2 (https=)
PL (1) PL2296672T3 (https=)
PT (1) PT2296672E (https=)
WO (1) WO2009150199A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2333047A1 (en) 2009-12-09 2011-06-15 Fresenius Medical Care Deutschland GmbH Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease
US8603470B1 (en) * 2012-08-07 2013-12-10 National Cheng Kung University Use of IL-20 antagonists for treating liver diseases
ES2759228T3 (es) 2013-07-05 2020-05-08 Univ Catholique Louvain Medio acondicionado de células madre de hígado de adultos y su uso en el tratamiento de trastornos del hígado
US10385114B2 (en) 2013-09-05 2019-08-20 Inis Biotech Llc SPARC (secreted protein, acidic and rich in cysteine), a new target for the treatment and prevention of acute liver failure
RU2644650C2 (ru) * 2014-12-01 2018-02-13 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток и способ его получения
CN104818245B (zh) * 2015-05-29 2020-02-04 广州赛莱拉干细胞科技股份有限公司 一种肝脏干细胞的培养基及培养方法
WO2017139455A1 (en) 2016-02-10 2017-08-17 Wake Forest University Health Sciences Model system of liver fibrosis and method of making and using the same
RU2708329C2 (ru) 2016-05-31 2019-12-05 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток, композиции и способы применения
WO2018119142A1 (en) 2016-12-21 2018-06-28 Amgen Inc. Anti-tnf alpha antibody formulations
JP2021526556A (ja) 2018-05-30 2021-10-07 ダイレクト バイオロジクス エルエルシー 成長因子および細胞外小胞を凍結または粉状にした、間葉系幹細胞(msc)の調製物を含む助剤、ならびにその使用方法
CN109628377A (zh) * 2019-01-02 2019-04-16 贵州省人民医院 一种小鼠原代肝细胞灌注式分离及离体培养方法
CN111607556B (zh) 2019-01-25 2022-06-07 中国科学院广州生物医药与健康研究院 一种培养扩增人肝祖细胞的培养基及其应用
BR112021015549A2 (pt) 2019-02-07 2021-10-26 Direct Biologics Llc Método para tratar osteoartrite com uma combinação de exossomos de células tronco mesenquimais, células tronco mesenquimais sinoviais e andaimes
DK3963050T3 (da) * 2019-04-30 2023-12-11 Cellaion Sa Forberedelse af humane allogene leverderiverede progenitorceller
CN111394391B (zh) * 2019-07-11 2022-12-06 上海赛立维生物科技有限公司 肝祖细胞样细胞库的构建方法及其制备的细胞株与应用
CA3146433A1 (en) 2019-07-18 2021-01-21 Direct Biologics Llc Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
US12590310B2 (en) 2020-04-22 2026-03-31 Direct Biologics, Llc Methods and compositions for treating inflammatory conditions associated with infectious disease
US12502407B2 (en) 2024-04-25 2025-12-23 Direct Biologics, Llc Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH093099A (ja) * 1995-06-20 1997-01-07 Toyobo Co Ltd マクロファージ刺激蛋白質改変体およびその製造法
US6475490B1 (en) * 1998-10-19 2002-11-05 Fordham University Compositions and methods for promoting tissue repair using heat shock proteins
US6372494B1 (en) * 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
US6719969B1 (en) * 1999-08-09 2004-04-13 The Regents Of The University Of Michigan Treatment of liver disease and injury with CXC chemokines
CA2290240C (en) * 1999-11-24 2008-03-11 Stergios Stergiopoulos High resolution 3d ultrasound imaging system deploying a multi-dimensional array of sensors and method for multi-dimensional beamforming sensor signals
US7547674B2 (en) * 2001-06-06 2009-06-16 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US6916770B2 (en) 2001-04-27 2005-07-12 Polyone Corporation Multi-functional color concentrate compositions
EP1406573A4 (en) * 2001-06-07 2005-03-30 Skinmedica Inc CONDITIONED CELL CULTURE MEDIA AND ITS USES
CA2463914A1 (en) * 2001-10-18 2003-04-24 Ixion Biotechnology, Inc. Conversion of liver stem and progenitor cells to pancreatic functional cells
WO2006126219A1 (en) 2005-05-26 2006-11-30 Fresenius Medical Care Deutschland G.M.B.H. Liver progenitor cells
CA2642664A1 (en) * 2006-02-16 2007-08-30 Burnham Institute For Medical Research Media conditioned by human embryonic stem cells or other progenitor cells and uses therefor
EP2422802A3 (en) * 2006-03-07 2013-03-06 Geeta Shroff Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
FR2912916B1 (fr) * 2007-02-26 2009-05-22 Oreal Composition cosmetique ou dermatologique comprenant un milieu de culture cellulaire

Similar Documents

Publication Publication Date Title
JP2011522553A5 (https=)
US20210008106A1 (en) Mitochondrial treatment of organs for transplantation
AU2019355201B2 (en) Methods for the expansion of mesenchymal stromal cells
Johansson et al. Mechanisms for absorption enhancement of inhaled insulin by sodium taurocholate
CN102985130A (zh) 移植来自实体组织的细胞的方法
CN110177872A (zh) 间充质干细胞和药物组合物
JP2023537204A (ja) 間葉系ストローマ細胞由来の細胞外小胞(ev)および前記evを得るための方法
CN107114356A (zh) 一种胎盘及脐带细胞保护液
CN105377275A (zh) 用于静脉给药的干细胞组合物
CA3134435A1 (en) Adult liver progenitor cells for treating acute-on-chronic liver failure
WO2023200882A1 (en) Compositions and methods for treating post acute sequelae of sars-cov-2 infection (long covid)
WO2021069553A1 (en) Use of liver progenitor or stem cells, lysates thereof, and/or conditioned medium in disorders characterized by vascular hyperpermeability
WO2020193715A1 (en) Adult liver progenitor cells for treating non-alcoholic fatty liver disease
WO2023077160A1 (en) Methods of treating diseases associated with cellular-energy deficiency or mitochondrial dysfunction by locoregional delivery of extracellular vesicles that have a cargo with an enhanced bioenergetic profile
CN101037667A (zh) 一种动物细胞的超低温保存溶液及保存方法
WO2021181394A1 (en) Methods and compositions for treating viral infections and sequelae thereof
CN107980767B (zh) 一种长期保存过表达ang-1的epc的保存液
Malmros et al. Dynamic accumulation of neutrophils in lungs and visceral organs during early abdominal sepsis in the pig
CN105532646A (zh) 肝细胞保存液及其制备方法和应用
JP7523441B2 (ja) Hla-eを発現する肝臓前駆細胞を含む細胞組成物
CN103301118A (zh) 注射用精氨酸布洛芬组合物
CN115715221A (zh) 用于治疗或预防多器官功能障碍综合征的组合物和方法
CN115627250B (zh) 用于培养昆虫细胞的无血清培养基及其应用
CN103301117A (zh) 注射用盐酸氨溴索组合物
US20260069745A1 (en) Biologic composition for promoting wound healing and a method of preparing the same